CN100415756C - 草酸阿地福韦酯及其晶型和制备方法及用途 - Google Patents
草酸阿地福韦酯及其晶型和制备方法及用途 Download PDFInfo
- Publication number
- CN100415756C CN100415756C CNB2003101048353A CN200310104835A CN100415756C CN 100415756 C CN100415756 C CN 100415756C CN B2003101048353 A CNB2003101048353 A CN B2003101048353A CN 200310104835 A CN200310104835 A CN 200310104835A CN 100415756 C CN100415756 C CN 100415756C
- Authority
- CN
- China
- Prior art keywords
- oxalic
- adefovir dipivoxil
- preparation
- ester
- adefovir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101048353A CN100415756C (zh) | 2003-10-14 | 2003-10-14 | 草酸阿地福韦酯及其晶型和制备方法及用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101048353A CN100415756C (zh) | 2003-10-14 | 2003-10-14 | 草酸阿地福韦酯及其晶型和制备方法及用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1528766A CN1528766A (zh) | 2004-09-15 |
CN100415756C true CN100415756C (zh) | 2008-09-03 |
Family
ID=34304282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2003101048353A Expired - Fee Related CN100415756C (zh) | 2003-10-14 | 2003-10-14 | 草酸阿地福韦酯及其晶型和制备方法及用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100415756C (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7935817B2 (en) * | 2008-03-31 | 2011-05-03 | Apotex Pharmachem Inc. | Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof |
CN102964384B (zh) * | 2012-11-09 | 2015-06-24 | 中山大学 | 阿德福韦酯没食子酸共晶及其制备方法和组合物 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1251592A (zh) * | 1997-07-25 | 2000-04-26 | 吉尔利德科学股份有限公司 | 核苷酸类似物组合物 |
CN1374314A (zh) * | 2002-03-13 | 2002-10-16 | 上海仲夏化学有限公司 | 阿德福韦酯无定形固化物及制备方法 |
CN1396170A (zh) * | 2002-07-08 | 2003-02-12 | 江苏正大天晴药业股份有限公司 | 匹伏阿德福韦的晶型 |
CN1425673A (zh) * | 2003-01-08 | 2003-06-25 | 北京博尔达生物技术开发有限公司 | 阿德福韦酯新晶态、新晶态组合物及其制备方法 |
CN1435420A (zh) * | 2002-11-19 | 2003-08-13 | 天津药物研究院 | 阿德福韦酯新结晶形态及其制备方法 |
-
2003
- 2003-10-14 CN CNB2003101048353A patent/CN100415756C/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1251592A (zh) * | 1997-07-25 | 2000-04-26 | 吉尔利德科学股份有限公司 | 核苷酸类似物组合物 |
CN1374314A (zh) * | 2002-03-13 | 2002-10-16 | 上海仲夏化学有限公司 | 阿德福韦酯无定形固化物及制备方法 |
CN1396170A (zh) * | 2002-07-08 | 2003-02-12 | 江苏正大天晴药业股份有限公司 | 匹伏阿德福韦的晶型 |
CN1435420A (zh) * | 2002-11-19 | 2003-08-13 | 天津药物研究院 | 阿德福韦酯新结晶形态及其制备方法 |
CN1425673A (zh) * | 2003-01-08 | 2003-06-25 | 北京博尔达生物技术开发有限公司 | 阿德福韦酯新晶态、新晶态组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1528766A (zh) | 2004-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102006200B1 (ko) | 매크로라이드의 결정 형태들 및 그 용도들 | |
KR100412298B1 (ko) | 콜로이드이산화규소를함유하는발라시클로비르정제 | |
RU2606628C2 (ru) | Моногидрат мезилата n-[5-(аминосульфонил)-4-метил-1,3-тиазол-2-ил]-n-метил-2-[4-(2-пиридинил)фенил]ацетамида, обладающий определенным диапазоном распределения частиц по размерам и удельной площади поверхности, для использования в фармацевтических препаратах | |
ES2562843T3 (es) | Forma IV de clorhidrato de ivabradina | |
KR100937184B1 (ko) | 리세드로네이트 나트륨의 신규한 동질이상체 및 유사동질이상체 | |
CN102086195B (zh) | 达沙替尼多晶型物及其制备方法和药用组合物 | |
US20160176912A1 (en) | Novel Ticagrelor Co-Crystal | |
JPH11503718A (ja) | グアニン誘導体 | |
CN104892604A (zh) | 一种新型的cdk4抑制剂的合成方法 | |
EA002970B1 (ru) | Новые кристаллические формы противовирусного соединения бензимидазола, способ их получения, их применение, фармацевтическая композиция и способ лечения | |
EP3585787A1 (en) | Crystalline forms of valbenazine salts | |
CN100415756C (zh) | 草酸阿地福韦酯及其晶型和制备方法及用途 | |
RU2485121C1 (ru) | Новые кристаллические формы адефовира дипивоксила и способы его получения | |
CN107652233B (zh) | 一种他克林-芥子酸杂合体的制备方法及用途 | |
KR20050086519A (ko) | 새로운 결정 형태를 가진 아데포비어 디피복실 및 그조성물 | |
WO2012055163A1 (zh) | 来曲唑i型结晶及其制备方法 | |
PL194752B1 (pl) | Krystaliczna postać VI 5,6-dichloro-2-(izopropyloamino)-1-(ß-L-rybofuranozylo)-1H-benzimidazolu, sposób jej wytwarzania, kompozycja farmaceutyczna zawierająca krystaliczną postać i zastosowanie krystalicznej postaci | |
TW553945B (en) | Triazolopurine derivatives, medicinal composition containing the derivatives, adenosine A3 receptor compatibilizing agent, and asthmatic remedy | |
KR101121589B1 (ko) | 안정성이 향상된 무정형 아데포비어 디피복실 고체분산체 및 이의 제조방법 | |
CN101070319B (zh) | 一种抗乙肝病毒化合物的结晶形态以及它的制备方法和用途 | |
JP2018518515A (ja) | フェニルアミノピリミジン化合物またはその塩の多形物 | |
JPH0340038B2 (zh) | ||
JPS5936696A (ja) | 2′―デオキシ―5―置換ウリジン誘導体及びそれを含有する抗腫瘍剤 | |
JPS59216899A (ja) | 2′―デオキシ―5―トリフルオロメチルウリジン誘導体及びそれを含む抗腫瘍剤 | |
KR101120120B1 (ko) | 무정형 아데포비아 디피복실을 포함하는 약학 조성물 및 이의 제조 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHENYANG PHARMACEUTICAL UNIVERSITY; APPLICANT Free format text: FORMER OWNER: SHENYANG PHARMACEUTICAL UNIVERSITY Effective date: 20070330 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20070330 Address after: 110015 large drug research institute, 103 Wenhua Road, Shenhe District, Liaoning, Shenyang Applicant after: Shenyang Pharmaceutical University Co-applicant after: Pharmaceutical General Factory, Hayao Group Address before: 110015 large drug research institute, 103 Wenhua Road, Shenhe District, Liaoning, Shenyang Applicant before: Shenyang Pharmaceutical University |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080903 Termination date: 20161014 |
|
CF01 | Termination of patent right due to non-payment of annual fee |